Monkeypox

August 10, 2022
The U..S Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) allowing healthcare providers to use an alternative dosing regimen of the JYNNEOS vaccine for individuals 18 years of age and older determined to be at high risk of monkeypox infection. This will increase the total number of doses available for use by up to five-fold.
July 15, 2022
All individuals are from LDH Region 1 (Orleans, Plaquemines, Jefferson, St. Bernard). No further information will be shared about these cases to protect the patients' privacy.
July 12, 2022
The Louisiana Department of Health (LDH) is reporting two new cases of monkeypox infection in Louisiana residents. Both individuals are from LDH Region 1 (Orleans, Plaquemines, Jefferson, St. Bernard). No further information will be shared about these cases to protect the patients' privacy.
July 07, 2022
The Louisiana Department of Health is reporting the first detected case of monkeypox infection in a Louisiana resident. This individual is from LDH Region 1 (Orleans, Plaquemines, Jefferson, St. Bernard).
Accessibility